S Sanofi
French multinational pharmaceutical and healthcare company
Updates & Highlights
Stock Titan · about 16 hours ago
Sanofi’s TZIELD approval triggers $24.5M payment to MacroGenics
BioSpace · about 20 hours ago
Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in
The Globe and Mail · about 22 hours ago
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
Recent Openings
View all 6 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Sanofi?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentSanofi’s TZIELD approval triggers $24.5M payment to MacroGenics
Sanofi’s TZIELD approval triggers $24.5M payment to MacroGenics
Stock Titan · about 16 hours ago
Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in
Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in
BioSpace · about 20 hours ago
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
The Globe and Mail · about 22 hours ago
Sofinnova, Sanofi alum unveil Bionyra with $165M and next-gen immunology assets
Sofinnova, Sanofi alum unveil Bionyra with $165M and next-gen immunology assets
BioSpace · about 22 hours ago
Backed by Sanofi and Roche, Orano Med chases radiopharma leadership
Backed by Sanofi and Roche, Orano Med chases radiopharma leadership
Pharma Voice · about 23 hours ago
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
Zacks Investment Research · about 24 hours ago
Sanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic disease
Sanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic disease
Fierce Biotech · about 24 hours ago
Can Sanofi buy its way into in vivo CAR-T?
Can Sanofi buy its way into in vivo CAR-T?
European Biotechnology Magazine · about 24 hours ago
Sanofi (NASDAQ: SNY) gains FDA nod for Tzield in stage 3 type 1 diabetes
Sanofi (NASDAQ: SNY) gains FDA nod for Tzield in stage 3 type 1 diabetes
Stock Titan · 1 day ago
Sanofi appoints Paulo Fontoura as Global Head of R&D
Sanofi appoints Paulo Fontoura as Global Head of R&D
FirstWord Pharma · 1 day ago
Paulo Fontoura to lead research and development at Sanofi
Paulo Fontoura to lead research and development at Sanofi
European Pharmaceutical Review · 1 day ago
Sanofi swaps R&D leaders; Merck’s Prometheus deal pays dividends
Sanofi swaps R&D leaders; Merck’s Prometheus deal pays dividends
Yahoo Finance · 1 day ago
Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm
Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm
MedCity News · 1 day ago
Helmed by Sanofi vet, Bionyra emerges with $165M and three licensed I&I assets
Helmed by Sanofi vet, Bionyra emerges with $165M and three licensed I&I assets
Fierce Biotech · 1 day ago
Bionyra's $165M launch: A Sanofi alum, I&I candidates from China, one big catch-up
Bionyra's $165M launch: A Sanofi alum, I&I candidates from China, one big catch-up
Endpoints News · 1 day ago
Sanofi R&D leader Houman Ashrafian to depart, Paulo Fontoura to take the reins
Sanofi R&D leader Houman Ashrafian to depart, Paulo Fontoura to take the reins
Endpoints News · 1 day ago
Sanofi appoints Paulo Fontoura as Global Head of R&D
Sanofi appoints Paulo Fontoura as Global Head of R&D
PMLiVE · 1 day ago
Sanofi names ex-Roche exec Fontoura as R&D chief
Sanofi names ex-Roche exec Fontoura as R&D chief
pharmaphorum · 1 day ago
Sanofi names Paulo Fontoura as global of R&D
Sanofi names Paulo Fontoura as global of R&D
The Pharma Letter · 1 day ago
Japan approves Sanofi’s Sarclisa combo for MM treatment
Japan approves Sanofi’s Sarclisa combo for MM treatment
Pharmaceutical Technology · 1 day ago